Ventricular arrhythmia discriminator programming and the impact on the incidence of inappropriate therapy in patients with implantable cardiac defibrillators

Indian Pacing and Electrophysiology Journal

Volumn 7, Issue 2, 2007, Pages 77-84

  Srivatsa, Uma N ^a   Hoppe, Bobbi L ^a   Narayan, Sanjiv ^a   Feld, Gregory K ^a   Birgersdotter Green, Ulrika ^a  

^a UCSD MEDICAL CENTER   (United States)

Author keywords

Implantable cardiac defibrillators; Inappropriate therapy; Ventricular arrhythmia discriminators

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOGENIC SHOCK; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONTROLLED STUDY; DEFIBRILLATOR; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; HEART ATRIUM FIBRILLATION; HEART VENTRICLE ARRHYTHMIA; HUMAN; INCIDENCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL ERROR;

EID: 34547857401     PISSN: None     EISSN: 09726292     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Grimm W, Flores B, Marchlinski F. Electrocardiographically documented unneccessary, spontaneous shocks in 241 patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 1992;15:1667-73.
2. Rosenqvist M, Beyer T, Block M, Kulk Kd, Minten J, F L. Adverse events with transvenous implantable cardioverter-defibrillators: a prospective multicenter study. European 7219 Jewel ICD investigators. Circulation 1998;98:663-70.
3. Quesada A, Almendral J, Arribas F, et al. The DATAS rationale and design: a controlled, randomized trial to assess the clinical benefit of dual chamber (DDED) defibrillator. Europace 2004;2:142-50.
4. Dorian P, Philippn F, Bernard T, et al. Randomized controlled study of detection enhancements versus rate-only detection to prevent inappropriate therapy in a dual chamber implantable cardioverter-defibrillator. Heart Rhythm 2004;1:540-547.
5. Young J, Abraham W, Smith A, et al. Combined Cardiac Resynchronization and Implantable Cardioversion Defibrillation in Advanced Chronic Heart Failure. The MIRACLE ICD Trial. JAMA 2003;280:2685-2694.
6. Guerra J, Wu J, Miller J, Groh W. Increase in Ventricular Tachycardia Frequency After Biventricular Implantable Cardioverter Defibrillator Upgrade. J Cardiovasc Electrophysiol 2003;14:1245-1247.
7. Schaumann A, Von Zur Muhlen F, Gonska B, Kreuzer H. Enhanced detection criteria in implantable cardioverter-defibrillators to avoid inappropriate therapy. Am J Cardiology 1996;5A:42-50.
8. Klein R, Raitt M, Wilkoff B, et al. Analysis of implantable cardioverter defibrillator therapy in the antiarrhythmics versus implantable defibrillators (AVID) trial. J. Cardiovasc. Electrophysiol. 2003;9:940-948.
9. Begley DA, Mohiddin SA, D T, Winkler JB, L F. Efficacy of implantable cardioverter defibrillator therapy for primary and secondary prevention of sudden cardiac death in hypertrophic cardiomyopathy. Pacing Clin Electrophysiol. 2003;9:1887-96.
10. Theuns DA, Klootwijk PJ, Goedhart DM, Jordaens LJ. Prevention of inappropriate therapy in implantable cardioverter-defibrillators. J Am Coll Cardiol. 2004;44:2362-7.
11. Nanthakumar K, Dorian P, Paquette M, et al. Is appropriate implantable defibrillator shock therapy predictable? J. Intervent Cardiac Electrophysiol. 2003;3:215-20.
12. Korte T, Koditz H, Niehaus M, Paul T, Tebbenjohanns J. High incidence of appropriate an inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2004;7:924-32.